EFFECTS OF CHRONIC AMANTADINE HYDROCHLORIDE INGESTION ON ITS AND ACETAMINOPHEN PHARMACOKINETICS IN YOUNG-ADULTS

被引:4
作者
AOKI, FY
SITAR, DS
机构
[1] UNIV MANITOBA,CLIN PHARMACOL SECT,770 BANNATYNE AVE,WINNIPEG R3E 0W3,MANITOBA,CANADA
[2] UNIV MANITOBA,INFECT DIS SECT,WINNIPEG R3E 0W3,MANITOBA,CANADA
[3] UNIV MANITOBA,DEPT INTERNAL MED,WINNIPEG R3E 0W3,MANITOBA,CANADA
[4] UNIV MANITOBA,DEPT MED MICROBIOL,WINNIPEG R3E 0W3,MANITOBA,CANADA
[5] UNIV MANITOBA,DEPT PHARMACOL & THERAPEUT,WINNIPEG R3E 0W3,MANITOBA,CANADA
关键词
D O I
10.1002/j.1552-4604.1992.tb03782.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The authors studied the effect of chronic amantadine ingestion on its own disposition and that of acetaminophen in five healthy young adults. The half-life of amantadine after 42 days ingestion was 15.1 +/- 2.3 hours and was not different from 14.8 +/- 4.4 hours after an acute ingestion (mean +/- SD). However, chronic amantadine ingestion was associated with an increased apparent volume of distribution for acetaminophen, 1.1 +/- 0.1 L/kg compared with 0.9 +/- 0.1 L/kg, when the two drugs were concurrently ingested after a 2-week washout period. This difference in kinetic distribution was not reflected in terminal acetaminophen half-life, 149 +/- 54 versus 151 +/- 55 minutes for chronic and acute amantadine ingestion, respectively. Plasma acetaminophen clearance with chronic amantadine ingestion (5.8 +/- 2.6 mL/min/kg) was not different from that determined after acute coingestion of both drugs (4.3 +/- 1.1 mL/min/kg). Thus, no change in recommended dose is necessary when these two drugs are coingested.
引用
收藏
页码:24 / 27
页数:4
相关论文
共 17 条
[1]   PROPHYLACTIC AMANTADINE DOSE AND PLASMA-CONCENTRATION EFFECT RELATIONSHIPS IN HEALTHY-ADULTS [J].
AOKI, FY ;
STIVER, HG ;
SITAR, DS ;
BOUDREAULT, A ;
OGILVIE, RI .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) :128-136
[2]   AMANTADINE KINETICS IN HEALTHY ELDERLY MEN - IMPLICATIONS FOR INFLUENZA PREVENTION [J].
AOKI, FY ;
SITAR, DS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) :137-144
[3]   CLINICAL PHARMACOKINETICS OF AMANTADINE HYDROCHLORIDE [J].
AOKI, FY ;
SITAR, DS .
CLINICAL PHARMACOKINETICS, 1988, 14 (01) :35-51
[4]  
AOKI FY, 1979, CLIN PHARMACOL THER, V26, P279
[5]  
BELANGER PM, 1979, J PHARMACOL EXP THER, V211, P485
[6]   GAS-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF AMANTADINE IN HUMAN PLASMA [J].
BIANDRATE, P ;
BELVEDERE, G ;
RIZZO, M ;
TOGNONI, G ;
FRIGERIO, A ;
MORSELLI, PL .
JOURNAL OF CHROMATOGRAPHY, 1972, 74 (01) :31-+
[7]  
BLEIDNER WE, 1965, J PHARMACOL EXP THER, V1503, P484
[8]   A PROSPECTIVE DOUBLE-BLIND-STUDY OF SIDE-EFFECTS ASSOCIATED WITH THE ADMINISTRATION OF AMANTADINE FOR INFLUENZA-A VIRUS PROPHYLAXIS [J].
BRYSON, YJ ;
MONAHAN, C ;
POLLACK, M ;
SHIELDS, WD .
JOURNAL OF INFECTIOUS DISEASES, 1980, 141 (05) :543-547
[9]  
CHANG KC, 1978, LANCET, V1, P1132
[10]   A FIELD TRIAL OF AMANTADINE PROPHYLAXIS IN NATURALLY-OCCURRING ACUTE RESPIRATORY ILLNESS [J].
FINKLEA, JF ;
HENNESSY, AV ;
DAVENPORT, FM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1967, 85 (03) :403-+